What This May Mean for Patients None of this regulatory context is unique to altRx, and altRx itself is one of many telehealth platforms operating in this space
GLP-1 Microdosing: What It Is, Why It's Growing in Popularity, and What the Research Says Over the past few years, GLP-1 receptor agonist medications have transformed the conversation around weight loss and metabolic health
A recent study shows people with obesity taking GLP-1 drugs are 20% less likely to suffer a cardiovascular event, and studies are under way for their use to treat the liver disease non-alcoholic steatohepatitis, as well as the neurodegenerative conditions Parkinsons and Alzheimers
Uneven suspension means inconsistent dosing
Appetite Control & Craving Reduction
Generally, fasting insulin and the total insulin output in response to intravenous glucose are reduced after bariatric surgery 55 , a pattern consistent with enhanced insulin sensitivity occurring in response to postoperative weight loss